-DNA 38 districts under Green Revolution II affected by slow poison Indian government's ambitious project Green Revolution-II (GR-II) to promote growing rice in the Eastern states of India is bringing arsenic to your plates. As many as 38 districts spreading across six states out of the seven states where the scheme is being implemented are reported to be affected by arsenic. These states are Bihar, West Bengal, Assam, Eastern Uttar Pradesh, Jharkhand...

-PTI New Delhi: Centre has asked states to set up vigilance committees to ensure transparency in supply of food grains through ration shops under the Public Distribution System (PDS). "States have been requested to set up vigilance committees at district, block and FPS level with due representation of SCs/STs, women and local bodies to ensure transparency and proper functioning of Targeted Public Distribution System (TPDS)," Paswan said in a Food Ministry statement. Chairing...

-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...

-The Hindustan Times New Delhi: For a long time, 12- year-old Rohan, an HIV positive child, was in pain but could not comprehend why. For months, he passed blood with his stools. Finally, a counsellor drew a sketch after Rohan pointed to his mouth and back and the truth emerged: He was regularly being forced into oral and anal sex. Rohan then drew a picture of Ashish, one of his co-inmates at...

-Economic and Political Weekly The key to improving the quality of healthcare services in India and reducing costs at the same time can be found by enacting legislation which lays down minimum standards of patient care. In the absence of such standards and the reluctance of health insurance companies to standardise either price or quality, healthcare services continue to be expensive and of doubtful quality. Developing standards of patient care by...